These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 10407995)

  • 21. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Umbilical cord blood transplantation--how, when and for whom?
    Cohen Y; Nagler A
    Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic peripheral blood stem cell transplantations in children--a single center experience.
    Sufliarska S; Horáková J; Bodová I; Martinka J; Hrubisko M; Kovács L; Jancovicová K; Lukác J
    Neoplasma; 2004; 51(2):110-6. PubMed ID: 15190420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic stem cell transplantation in children with hematological malignancies across HLA barriers--reasonable alternative?
    Sedlácek P; Starý J; Vodváková S; Poloucková A; Gasová Z; Marinov I; Formánková R
    Neoplasma; 2001; 48(4):302-6. PubMed ID: 11712683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors.
    Matsuda Y; Hara J; Osugi Y; Fujisaki H; Takai K; Ohta H; Nakanishi K; Tokimasa S; Miyoshi H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 1998 Feb; 21(4):355-60. PubMed ID: 9509968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
    Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
    J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Umbilical cord blood transplantation from unrelated HLA-matched donor in an adult with severe aplastic anemia.
    Mao P; Liao C; Zhu Z; Wang H; Wang S; Xu Y; Mo W; Ying Y; Li Q; Liu B
    Bone Marrow Transplant; 2000 Nov; 26(10):1121-3. PubMed ID: 11108315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
    Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia.
    Iori AP; Screnci M; Guglielmi C; Mengarelli A; Carmini D; Testi AM; Moleti ML; Cimino G; Perrone P; Laurenti L; Elia L; Boecklin F; Romano A; Vulcano F; De Felice L; Arcese W
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S75. PubMed ID: 9715896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
    Howrey RP; Martin PL; Driscoll T; Szabolcs P; Kelly T; Shpall EJ; Bearman SI; Slat-Vasquez V; Rubinstein P; Stevens CE; Kurtzberg J
    Bone Marrow Transplant; 2000 Dec; 26(11):1251-4. PubMed ID: 11149743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
    Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
    Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia.
    Boiron JM; Cotterêt S; Cony-Makhoul P; Merel P; Micheau M; Perel Y; Belloc F; Bernard P; Reiffers J
    Bone Marrow Transplant; 1998 Oct; 22(8):819-21. PubMed ID: 9827983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia.
    Chan KW; McDonald L; Lim D; Grimley MS; Grayson G; Wall DA
    Bone Marrow Transplant; 2008 Nov; 42(9):589-95. PubMed ID: 18695669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.